What Digital Pharma Lab does

Digital Pharma Lab is a Paris-based healthcare innovation consultancy, legally operating as a brand of D2A SAS and founded in 2017. The firm sells advisory services across seven practice areas (Innovation Management, AI in Healthcare, AI and Rare Diseases, Marketing and Engagement, Medical R&D, Healthcare Market Access, and Longevity), supplemented by a professional training Academy, and operates as a coordinator of branded coalitions including NextGen Coalition and Coalition IDEO that link pharmaceutical companies, MedTech firms, healthcare institutions, and digital health startups. The company reports cumulative activity of 150+ innovation projects, 90+ industry-startup collaborations, 7 coalitions, and 80,000+ patients impacted by supported solutions.

The business runs on a professional-services revenue model with project-based pricing that is not publicly disclosed, and it pursues a dual go-to-market combining consultative direct enterprise sales with community-led coalition events such as the recurring NextGen Coalition Pitch Days. Named clients include ten major pharmaceutical companies (Lilly, Ipsen, Novartis, Sanofi, Pfizer, Roche, GSK, Chugai, Indivior, Takeda), Medtronic, and three healthcare institutions (AP-Hôpitaux de Paris, Institut Bergonié, Institut Curie). Strategic alliances with EIT Health, BPI France, Medicen, and IFIS anchor the firm's European ecosystem positioning, while a Data Consortium initiative signals an emerging move from pure services toward shared data infrastructure.

The company employs between 11 and 50 people and operates in Europe, primarily France. There are no disclosed funding rounds, acquisitions, or revenue figures. AI is positioned as an applied advisory layer rather than as proprietary technology: the firm markets generative AI and natural language processing capabilities to support healthcare innovation projects, with no evidence of in-house model development, patents on AI systems, or disclosed benchmark performance. Co-founders Didier Tranchier and Pascal Bécache lead the firm.

Name

Digital Pharma Lab

Legal name

D2A SAS

Website

https://digitalpharmalab.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Digital Pharma Lab is a Paris-based healthcare innovation consultancy that advises pharmaceutical companies, MedTech firms, healthcare institutions, and digital health startups on AI adoption, innovation management, and market access, while coordinating branded health coalitions across Europe.

Ownership category

akta.pro rank

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Healthcare Innovation Consulting: The company provides consulting services for healthcare innovation including innovation management, AI implementation, R&D advisory, and market access strategy. This appears to be their primary revenue stream.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Digital Pharma Lab is a Paris-based healthcare innovation consultancy that advises pharmaceutical, MedTech, healthcare institutions, and digital health startups on innovation management, AI in healthcare, AI and rare diseases, medical R&D, market access, marketing and engagement, and longevity. The firm complements its advisory practice with collaborative ecosystem programs (NextGen Coalition, Coalition IDEO, Data Consortium) and a professional training Academy.

Product overview

Digital Pharma Lab operates as a healthcare innovation consultancy offering a platform of advisory services rather than a single software product. The company provides expertises across innovation management, AI in Healthcare, AI and Rare Diseases, Marketing and Engagement, Medical R&D, Healthcare Market Access, and Longevity. Services are organized into three main offerings: (1) Innovate and Transform - accelerating digital health innovation projects with laboratories and manufacturers; (2) Train and Challenge - training teams and processes; and (3) Collaborate and Experiment - promoting collaborative innovation through ecosystem coalitions including NextGen Coalition, Coalition IDEO, and a Data Consortium. The company also maintains an Academy for professional formations.

Differentiator

Problem solved

Functional benefit

Brands

• Digital Pharma Lab: Healthcare innovation consultancy brand
• Étincelle Digitale
• Coalition Next
• NextGen Coalition
• Coalition IDEO
• Innosanté
• SISO
• Open Design Thinking

Products and services

• Innovation Management Consulting (Management de l'innovation) Advisory services that help pharmaceutical companies, MedTech firms, and healthcare organizations structure, accelerate, and execute digital health innovation projects from concept to deployment.
• AI in Healthcare Consulting (IA en Santé) Consulting services applying artificial intelligence to healthcare transformation, including generative AI and natural language processing advisory for pharma and healthcare institutions.
• AI and Rare Diseases Consulting (IA et Maladies Rares) Specialized consulting services applying AI technologies to rare disease research, treatment development, and patient pathway design.
• Marketing and Engagement Consulting Consulting services for healthcare marketing strategy, patient engagement, and healthcare professional engagement optimization.
• Medical R&D Consulting (R&D médicale) Advisory services supporting medical research and development initiatives within pharmaceutical and healthcare organizations.
• Healthcare Market Access Consulting (Market Access santé) Consulting services for healthcare market access strategies, reimbursement navigation, and regulatory pathway planning.
• Longevity Consulting (Longévité) Specialized consulting focused on longevity, preventive health, and healthy aging solutions for pharmaceutical laboratories.
• Academy (Académie) Professional training and educational programs delivered to industry professionals on AI, digital health, and healthcare innovation topics.
• NextGen Coalition A coalition program offering startups privileged access to hospitals, pharmaceutical companies, and collaborative experimentation opportunities.
• Coalition IDEO (Innovation Officine) A coalition focused on innovation in pharmacy practice, bringing together multiple stakeholders for collaborative healthcare innovation.
• Data Consortium (Consortium de données) A data intelligence initiative enabling collaborative data sharing and analysis across healthcare ecosystem participants.

Quantifiable outcome

• 80,000+ patients impacted by supported solutions
• +3 more outcomes

Named customers14 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• IFIScoreStrategic or Co-development PartnerNew partnership announced in 2025. IFIS is a strategic partner collaborating with Digital Pharma Lab on healthcare innovation initiatives.
• EIT HealthcoreStrategic or Co-development PartnerEuropean health innovation network supporting Digital Pharma Lab's ecosystem development and startup collaborations.
• BPI FrancecoreStrategic or Co-development PartnerFrench public investment bank supporting healthcare innovation ecosystem and Digital Pharma Lab's initiatives.
• MedicencoreStrategic or Co-development PartnerParis region health innovation cluster partnering with Digital Pharma Lab for healthcare ecosystem development.
• ServierminorStrategic or Co-development PartnerPharmaceutical company collaborating through coalition initiatives. Digital Pharma Lab helped accelerate Servier projects with startups.
• IntertiominorStrategic or Co-development PartnerStartup member of the ecosystem. Digital Pharma Lab provided visibility with pharmaceutical companies and board presentation opportunities.
• Epigene LabsminorStrategic or Co-development PartnerStartup partner where Digital Pharma Lab orchestrated efficient collaboration on a Servier project, creating urgency and accelerating processes.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Bain & Company (Healthcare practice): Global consulting firm with a dedicated healthcare and life sciences practice, including pharma R&D and digital health advisory. Frequently engages the same enterprise pharma clients as DPL on broader strategic and operational mandates.
• ZS Associates: Large global consulting firm dedicated to pharma, biotech, and medical technology. Overlaps directly with DPL's pharma/MedTech consulting mandate but at substantially greater scale, broader geographic reach, and deeper commercial and R&D analytics capability.
• Capgemini Invent: The innovation, strategy, and digital transformation arm of Capgemini with a strong life sciences practice. Competes for pharma innovation and digital transformation mandates where DPL is engaged, but with broader portfolios and global delivery capacity.
• IQVIA: Global leader in life sciences R&D and commercial services, including market access and real-world evidence. Directly comparable in market access and pharma advisory services, but operates at vastly larger scale with proprietary data assets.
• McKinsey (Health Tech and Pharma practices): Global strategy consultancy with dedicated healthcare, pharma, and digital health practices. Pursues many of the same innovation, AI, and digital transformation mandates as DPL at the top of the pharma market.

Others

• EIT Health: EU-funded pan-European health innovation network and one of DPL's strategic partners. Functions as an ecosystem enabler and referral channel rather than a competitor, but overlaps thematically as a convener of pharma, hospitals, and startups across Europe.

Direct peers

• Alcimed: French-headquartered innovation and new business development consultancy with a major healthcare and life sciences vertical. Closely comparable boutique model selling bespoke innovation scouting, market access, and AI advisory to pharma and MedTech clients across Europe.
• Kea & Partners: Paris-based transformation consultancy focused on healthcare, pharmaceuticals, and insurance. Similar DNA — boutique, healthcare-specialized, partnering with pharma on digital and innovation mandates — making them a head-to-head peer for enterprise pharma advisory engagements.
• Tilt Ideas: French boutique innovation consultancy (formerly Tilt-ideas) working across healthcare, energy, and mobility. Comparable scale and operating model: mission-led innovation accelerator, ecosystem orchestration, and corporate-startup matchmaking similar to the NextGen Coalition.

Emerging players

• Kamet Ventures: European health and insurance technology venture builder headquartered in Paris. Comparable as a Paris-based, healthcare-focused innovation ecosystem player, but oriented toward building startups rather than consulting on innovation projects.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Digital Pharma Lab